Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics

MARSEILLE, France, October 30, 2023--Vect-Horus announced it has entered into a global license agreement with Novo Nordisk A/S.

Related Keywords

France ,Brian Vandahl ,Alexandre Tokay ,Novo Nordisk ,Michel Khrestchatisky ,Global Research Technologies At Novo Nordisk ,Aix Marseille University ,Institute For Neurophysiopathology ,Senior Vice President ,Global Research Technologies ,Therapeutic Molecules ,Ect Horus ,